Aging Owners' Inventory Release Over Next Decade Unlikely to Solve Housing Shortage, Realtor.com Says
MT newswire2026/10/05 19:3803:38 PM EDT, 10/05/2026 (MT Newswires) -- Aging US homeowners are expected to release nearly 14 million homes over the next 10 years, though the turnover alone is unlikely to help eliminate the country's housing gap, News Corp's (NWS, NWSA) Realtor.com said Monday. Baby Boomers and the Silent Generation are likely to free up 13.9 million homes over the next decade, marking a 34% increase over what older households relinquished 10 years ago, or a 74% surge over what Boomers and the Silent Generation gave back a decade earlier, according to the online real estate portal. However, of the total, only 380,000 starter homes are expected to be relinquished by the older groups, partly because owners of smaller houses are more likely to have paid off their mortgages and stay put. Family homes account for 9.9 million of the total. The generational handoff includes homes vacated via death, a move to institutional care, household consolidation or a move to a rental, according to Realtor.com. "The handoff is a welcome relief, but it is not big enough to solve the housing shortage issue alone," Realtor.com Senior Economist Jiayi Xu said. "Keeping homeownership within reach for the next generation, and keeping these homes a source of family wealth, will still take more supply, especially homes first-time buyers can afford, particularly in expensive markets." Although houses freed up by the aging population help ease inventory constraints caused by underbuilding and rate lock-in, they are not likely to arrive all at once, Realtor.com said. The entry-level segment, where the shortage is most acute for first-time homebuyers, gets the least relief, while affordability is expected to see a "smaller improvement" over the next 10 years, according to the report. Earlier this year, a report by Realtor.com showed that new home construction in the US last year fell short of household formations, increasing the housing supply gap to an estimated 4.03 million units. The influx of inventory is expected to concentrate primarily in Rust Belt
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley senior bond investor turns bullish on US Treasuries for the first time in ten years
US Stock Movement | SuperX AI Technology (SUPX.US) once fell more than 2.5%, hitting an intraday low of $6.46
SuperX AI Technology's stock price declined, falling more than 2.5% at one point.
BUZZ-Pacira BioSciences participated in a Viatris acquisition deal worth 1.65 billions dollars
Latest Update October 8 – Pacira BioSciences (PCRX.O) shares surged by 44%, hitting a more than three-year high at $36.30. If the rally holds, PCRX is poised for its largest single-day gain on record. Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences in a $1.65 billion cash deal, offering $36.50 per share. The offer represents a premium of approximately 44.8% over Pacira’s recent closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris' product portfolio. Viatris shares fell 2.6% to $17.04. JPMorgan stated: “We believe this acquisition will not significantly alter VTRS' overall financial profile in the short or long term, and expect Exparel’s sales to gradually decline post-2030 due to generic market entry.” Both parties expect to complete the transaction by the end of 2026. Including intraday fluctuations, PCRX shares have risen 40.2% year-to-date, while VTRS has gained 36.8%. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translated texts and provides them for readers’ convenience only. Reuters assumes no liability for any damage or losses resulting from the use of automated translation.)